ITC Receives Section 337 Complaint on Dermatological Treatment Devices

Comments are due March 16 regarding a potential International Trade Commission investigation on imported dermatological treatment devices, a Federal Register notice said (ITC docket no. 3670). The notice follows a March 1 complaint by Serendia, which alleged that 15 named respondents import and sell products that infringe six of Serendia's patents. The patents concern methods and items for treating skin tissue using bipolar electrodes in portable devices. Serendia has asked the ITC for a permanent limited exclusion order barring from entry all infringing devices and components manufactured or imported by the respondents or their affiliates along with cease-and-desist orders. The named respondents are: